Variant report
Variant | nsv971607 |
---|---|
Chromosome Location | chr8:130487651-130489151 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:130476943..130484127-chr8:130486022..130491772,8 | K562 | blood: | |
2 | chr8:130478286..130480588-chr8:130485205..130487695,3 | K562 | blood: | |
3 | chr8:130474372..130477714-chr8:130485477..130488495,3 | K562 | blood: | |
4 | chr8:130486576..130489479-chr8:130489655..130491776,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1108353 | chr8:130487654-130487655 | Weak transcription Enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs74727147 | chr8:130487686-130487687 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs1108352 | chr8:130487710-130487711 | Weak transcription Enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs186344986 | chr8:130487713-130487714 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs575990296 | chr8:130487778-130487779 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs145426734 | chr8:130487861-130487862 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs147284795 | chr8:130487885-130487886 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs140670998 | chr8:130487900-130487901 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs541255179 | chr8:130487906-130487907 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs559602808 | chr8:130487920-130487921 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192356006 | chr8:130487926-130487927 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs551750143 | chr8:130487938-130487939 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182509139 | chr8:130487977-130487978 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs530945353 | chr8:130487986-130487987 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs561981120 | chr8:130488031-130488032 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549175908 | chr8:130488194-130488195 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs144622347 | chr8:130488226-130488227 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs147843139 | chr8:130488239-130488240 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs148907598 | chr8:130488269-130488270 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs187986181 | chr8:130488329-130488330 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142729641 | chr8:130488334-130488335 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs556951272 | chr8:130488341-130488342 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs566768011 | chr8:130488397-130488398 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs558039223 | chr8:130488404-130488405 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs529109479 | chr8:130488430-130488431 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs537070246 | chr8:130488437-130488438 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs555021642 | chr8:130488438-130488439 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs573435505 | chr8:130488452-130488453 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73391878 | chr8:130488464-130488465 | Weak transcription Enhancers Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs114703269 | chr8:130488532-130488533 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs150978890 | chr8:130488560-130488561 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545337930 | chr8:130488590-130488591 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs564026395 | chr8:130488643-130488644 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs373608292 | chr8:130488657-130488658 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs533703812 | chr8:130488815-130488816 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs551974043 | chr8:130488827-130488828 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530786172 | chr8:130488837-130488838 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543074418 | chr8:130488842-130488843 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs561354575 | chr8:130488863-130488864 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs576936839 | chr8:130488867-130488868 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs192701933 | chr8:130488880-130488881 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs16904084 | chr8:130488965-130488966 | Weak transcription Enhancers Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs34325647 | chr8:130488991-130488992 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565836608 | chr8:130489003-130489004 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs533166069 | chr8:130489034-130489035 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs57020441 | chr8:130489048-130489049 | Weak transcription Enhancers Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs569961114 | chr8:130489053-130489054 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs553424664 | chr8:130489058-130489059 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs536626548 | chr8:130489092-130489093 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs554984358 | chr8:130489097-130489098 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Gastric cancer | 21528007 | CNVD |
Breast cancer | 22532251 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21129771 | CNVD |
benign familial neonatal convulsions | 18472482 | CNVD |
Breast cancer | 16417655 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21183584 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Breast cancer | 20814816 | CNVD |
Colorectal cancer | 22486879 | CNVD |
Breast cancer | 17908964 | CNVD |
Colorectal cancer | 20031965 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Ovarian cancer | 17908964 | CNVD |
Ovarian cancer | 20031965 | CNVD |
Prostate cancer | 20031965 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Prostate cancer | 19242612 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 22048815 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Lung adenocarcinoma | 21148746 | CNVD |
Lung cancer | 21911935 | CNVD |
Breast cancer | 20459607 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 22860045 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Lung cancer | 17925434 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Prostate cancer | 17217626 | CNVD |
Cancer | 17160897 | CNVD |
Breast cancer | 16497871 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Cystic fibrosis | 19273617 | CNVD |
Chronic stroke | 19622162 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 17850661 | CNVD |
head and neck squamous cell carcinoma | 16740747 | CNVD |
Gastric cancer | 22539939 | CNVD |
Breast cancer | 16272173 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 16620391 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:130475800-130492000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr8:130483400-130487800 | Strong transcription | K562 | blood |
3 | chr8:130484600-130489000 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr8:130485600-130491400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
5 | chr8:130486200-130488600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr8:130487200-130488800 | Enhancers | Fetal Stomach | stomach |
7 | chr8:130487400-130488400 | Enhancers | Colon Smooth Muscle | Colon |
8 | chr8:130487600-130488400 | Enhancers | Rectal Smooth Muscle | rectum |
9 | chr8:130487600-130489000 | Enhancers | Fetal Thymus | thymus |
10 | chr8:130487800-130488000 | Enhancers | H9 Cell Line | embryonic stem cell |
11 | chr8:130487800-130488000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
12 | chr8:130487800-130488200 | Enhancers | Stomach Smooth Muscle | stomach |
13 | chr8:130487800-130494800 | Genic enhancers | K562 | blood |
14 | chr8:130488000-130489400 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
15 | chr8:130488000-130489400 | Enhancers | Dnd41 | blood |
16 | chr8:130488000-130492600 | Weak transcription | H9 Cell Line | embryonic stem cell |
17 | chr8:130488200-130489000 | Enhancers | Thymus | Thymus |
18 | chr8:130488200-130491600 | Weak transcription | Stomach Smooth Muscle | stomach |
19 | chr8:130488400-130491400 | Weak transcription | Colon Smooth Muscle | Colon |
20 | chr8:130488400-130491800 | Weak transcription | Rectal Smooth Muscle | rectum |
21 | chr8:130488600-130488800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
22 | chr8:130488800-130489200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
23 | chr8:130488800-130491600 | Weak transcription | Fetal Stomach | stomach |
24 | chr8:130489000-130490200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
25 | chr8:130489000-130490400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
26 | chr8:130489000-130490400 | Enhancers | Osteobl | bone |
27 | chr8:130489000-130490600 | Enhancers | NH-A | brain |